Bristol-Myers Squibb
BMY
BMY
1,810 hedge funds and large institutions have $69.6B invested in Bristol-Myers Squibb in 2019 Q3 according to their latest regulatory filings, with 146 funds opening new positions, 725 increasing their positions, 703 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,810
Holders Change
+35
Holders Change %
+1.97%
% of All Funds
39.75%
Holding in Top 10
48
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+26.32%
% of All Funds
1.05%
New
146
Increased
725
Reduced
703
Closed
97
Calls
$1.66B
Puts
$1.7B
Net Calls
-$38.8M
Net Calls Change
+$52M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$612M |
| 2 |
JPMorgan Chase & Co
New York
|
+$543M |
| 3 |
BlackRock
New York
|
+$467M |
| 4 |
IFP
Independent Franchise Partners
London,
United Kingdom
|
+$399M |
| 5 |
AIG
American International Group
New York
|
+$385M |
